Landscapes / Companies
Cytokinetics not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials · 6 in all
Trials
5 active
26 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | Mar 2029Phase 2/3 trial completes | |||
| Next date | Mar 2029 · Phase 2/3 trial completes | ||||
| Also tested for | Symptomatic Hypertrophic Cardiomyopathy (HCM), Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy and 2 more | ||||
| Open drug page | |||||
— |
Phase 3 | Sep 2027Phase 3 trial completes | |||
| Next date | Sep 2027 · Phase 3 trial completes | ||||
| Also tested for | Heart Failure, Heart Failure With Reduced Ejection Fraction | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF) | ||||
| Open drug page | |||||
About
- No active trial
- CK-3828136, Reldesemtiv, tirasemtiv
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021